+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Treatment of acute hepatitis C with interferon alpha-2b prevents chronicity

Treatment of acute hepatitis C with interferon alpha-2b prevents chronicity

Hepatology 30(4 PART 2): 264A

(PDF emailed within 1 workday: $29.90)

Accession: 035980764

Download citation: RISBibTeXText

Related references

High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study. Digestive Diseases and Sciences 41(12 Suppl): 81s-85s, 1996

Interferon prevents chronicity of acute hepatitis C transmitted by accidental needlestick. Hepatology 24(4 PART 2): 573A, 1996

Pathogenesis of experimental neonatal woodchuck hepatitis virus infection: chronicity as an outcome of infection is associated with a diminished acute hepatitis that is temporally deficient for the expression of interferon gamma and tumor necrosis factor-alpha messenger RNAs. Hepatology 33(2): 439-447, 2001

Early treatment of acute hepatitis C with interferon alpha-2b or interferon alpha-2b plus ribavirin: study of sixteen patients. Gastroenterologie Clinique et Biologique 27(3 Pt 1): 294-299, 2003

Natural interferon alpha treatment and interferon alpha receptor 2 levels in acute hepatitis C. Digestive Diseases and Sciences 49(2): 289-294, 2004

Combination therapy with ribavirin plus alpha interferon for the treatment of chronic hepatitis secondary to hepatitis C virus in patients who have failed treatment with alpha interferon. Gastroenterology 114(4 PART 2): A1281, April 15, 1998

Recombinant alpha 2b interferon in acute hepatitis C: Results of the treatment and determination of anti-interferon antibodies. Biotecnologia Aplicada 14(4): 242-247, 1997

Disappearance of serum hepatitis C virus RNA within two days after one dose interferon administration is predictive for response to high-dose interferon-alpha 2b treatment for chronic hepatitis C. Keio Interferon-alpha 2b Study Group. Keio Journal of Medicine 46(2): 74-80, 1997

Double-blind, placebo-controlled trial of interferon alpha-2b plus ribavirin versus interferon alpha-2b for retreatment of patients with chronic hepatitis C who failed previous treatment with interferon alpha. Hepatology 28(4 PART 2): 703A, 1998

Clearance of hepatitis c virus with the optimal cyclic and periodic interferon treatment regimen consisting of induction treatment with natural interferon beta followed by maintenance treatment with interferon alpha in interferon resistant patients. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No T1224, 2003

Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma. Journal of Viral Hepatitis 17(4): 287-292, 2010

Interferon-alpha alone versus interferon-alpha plus ribavirin in patients with chronic hepatitis C not responding to previous interferon-alpha treatment. Biodrugs 13(4): 299-304, 2007

Efficacy of alfa interferon to prevent chronicity in patients with acute posttransfusion non a non b hepatitis a randomized controlled trial. Journal of Hepatology 9(SUPPL 1): S241, 1989

Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b. Digestive and Liver Disease 37(11): 882-885, 2005